REFERENCES
- Law MJ, Lower KM, Voon HPJ, . ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell. 2010;143(3):367–378.
- Steensma DP, Gibbons RJ, Higgs DR. Acquired α-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. Blood. 2005;105(2):443–452.
- Greenberg P, Cox C, LeBeau MM, . International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079–2088.
- Malcovati L, Germing U, Kuendgen A, . Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007;25(23):3503–3010.
- Badens C, Martini N, Courrier S, . ATRX syndrome in a girl with a heterozygous mutation in the ATRX Zn finger domain and a totally skewed X-inactivation pattern. Am J Med Genet. A. 2006;140(20):2212–2215.
- Steensma DP, Higgs DR, Fisher CA, Gibbons RJ. Acquired somatic ATRX mutations in myelodysplastic syndrome associated with α thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations. Blood. 2004;103(6):2019–2026.
- Serrano E, Lasa A, Perea G, . Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures. Acta Haematol. 2006;116(2):77–89.
- Rose C, Fournier M, Nibourel O, . Acquired α thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy. Leuk Res. 2011;35(11):e203–e205.
- Park S, Kelaidi C, Sapena R, . Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: a retrospective analysis on 112 patients. Leuk Res. 2010;34(11):1430–1436.